Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Prospective Unmasked Randomized Evaluation Of The Istent Inject (®) Versus Two Ocular Hypotensive Agents In Patients With Primary Open-Angle Glaucoma., Antonio M Fea, Jose I Belda, Marek Rękas, Anselm Jünemann, Lydia Chang, Luis Pablo, Lilit Voskanyan, L Jay Katz
Prospective Unmasked Randomized Evaluation Of The Istent Inject (®) Versus Two Ocular Hypotensive Agents In Patients With Primary Open-Angle Glaucoma., Antonio M Fea, Jose I Belda, Marek Rękas, Anselm Jünemann, Lydia Chang, Luis Pablo, Lilit Voskanyan, L Jay Katz
Wills Eye Hospital Papers
PURPOSE: The purpose of this study was to compare outcomes of subjects with open-angle glaucoma (OAG) not controlled on one medication who underwent either implantation of two iStent inject (®) trabecular micro-bypass devices or received medical therapy consisting of a fixed combination of latanoprost/timolol.
PATIENTS AND METHODS: Of 192 subjects who qualified for the study and were enrolled, 94 were randomized to surgery with implantation of two iStent inject(®) devices in the treated eye and 98 to receive medical therapy.
RESULTS: At the month 12 visit, 94.7% of eyes (89/94) in the stent group reported an unmedicated intraocular pressure (IOP) …